Wells Fargo & Company HAEMONETICS CORP MASS Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024
Number of Shares
13,883,000
Previous 17,118,000 18.9%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024
SELL
N/A
-3,235,000 Reduced 18.9%
13,883,000 $0
Q1 2024

May 10, 2024
SELL
N/A
-2,443,000 Reduced 12.49%
17,118,000 $0
Q4 2023

Feb 09, 2024
BUY
N/A
498,000 Added 2.61%
19,561,000 $0
Q3 2023

Nov 13, 2023
BUY
N/A
2,499,000 Added 15.09%
19,063,000 $0
Q2 2023

Aug 15, 2023
BUY
N/A
6,433,000 Added 63.5%
16,564,000 $0
Q1 2023

May 12, 2023
BUY
N/A
2,747,000 Added 37.2%
10,131,000 $0
Q4 2022

Feb 13, 2023
BUY
N/A
125,000 Added 1.72%
7,384,000 $0
Q2 2022

Aug 12, 2022
BUY
N/A
7,144,000 Added 6212.17%
7,259,000 $5.75 Million
Q1 2022

May 16, 2022
BUY
N/A
115,000 New
115,000 $98,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email